Forum Replies Created
-
Posts
-
Thanks, Maria, for posting this article. The statistics shocked me. I think patients need to be more aware of long-term risks and what to look for as far as symptoms.
Jeff- I agree with that patients are not being scanned properly prior to starting treatment and during treatment. I think we can do better at monitoring patients before, during and after.
Hi , My name is Wanda Monroe. I work in BSH Infusion.
1. What was the knowledge gained?
Before reading this article, I had no idea the cardiac toxicities related to immunotherapy. We give a lot of combination treatments with immunotherapy and chemotherapy. It does surprise me that we are not monitoring patients closer for these side effects. It’s also concerning that symptoms can be similar to normal chemo side effects. My knowledge gained is awareness.
2. 2. Will this information change my practice?
Definitely. During my assessment of patients, I will keep in mind symptoms to look for regarding Cardio toxicities. I will also bring these symptoms to attention with the clinic team.
3. 3. What other questions does the article raise about current practice?
The question I have is why are we not scanning these patients for cardiac issues prior to starting treatment? What are we doing to monitor these patients during there treatment. Many of these patients receive immunotherapy for years.
